Hair Loss Drug Under Review
Popular hair loss medication Finasteride has come under scrutiny by the European health regulator. While treatments for hair loss can be life-changing for those experiencing thinning hair or baldness, it’s essential to stay informed about potential risks associated with these medications.
Here, we explore why Finasteride is being reviewed and what it could mean for those considering or currently using the drug.
Why is Finasteride being reviewed?
The European Medicines Agency (EMA) has announced a review of Finasteride following concerns about possible psychiatric side effects, including depression and suicidal thoughts. The drug is currently prescribed in low doses to treat male pattern baldness and in higher doses for prostate enlargement.
The EMA’s Pharmacovigilance Risk Assessment Committee (PRAC) is set to evaluate all available data. This will help them to determine whether the risks outweigh the benefits of the drug, and if any regulatory actions are necessary.
Understanding Finasteride and its uses
Finasteride works by inhibiting the conversion of testosterone to dihydrotestosterone (DHT), a hormone linked to hair loss in men. By reducing DHT levels, Finasteride can effectively slow down hair loss and, in some cases, promote regrowth. It has been approved and widely used for years, offering hope to millions struggling with hair loss.
However, like all medications, Finasteride isn’t without side effects. Commonly reported issues include decreased libido, erectile dysfunction, and ejaculation disorders. Until recently, psychiatric side effects were considered rare, but emerging evidence suggests they may be more significant than previously thought.
NHS warnings highlight potential risks
Earlier this year, the NHS issued a warning to men taking Finasteride, to remain vigilant for possible psychiatric and sexual side effects.
Patients were advised to seek immediate medical attention if they experience symptoms such as depression, mood changes, or suicidal thoughts. Healthcare professionals were also reminded to discuss these risks with patients before initiating treatment.
What should patients do?
If you’re currently taking Finasteride or considering it as a treatment option, speak with your healthcare provider. They can provide personalised advice based on your medical history and current health.
Pay attention to any changes in your mood, mental health, or sexual function. Keeping a journal can help track any symptoms that may crop up. If you experience any adverse effects, report them to your doctor immediately.
There are other treatments for hair loss, including topical solutions like minoxidil, laser therapy, and surgical options like hair transplantation. Discuss these alternatives with your doctor to determine the best course of action.
Conclusion
Hair loss can be a distressing experience, and finding an effective treatment is a priority for patients. While Finasteride has offered hope to those struggling with hair thinning and baldness, it’s crucial to stay informed about potential risks.
If you’re affected by these recent developments or have concerns about your treatment, don’t hesitate to reach out to a dermatologist that specialises in hair loss.
